GHRP-2 10 mg

GHRP-2 10 mg – characteristics

GHRP-2 10 mg is a synthetic research peptide included in the group of growth hormone secretagogues. The molecule consists of six amino acid residues and is identified by the sequence D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH₂, which forms the basis of its structural classification as a short hexapeptide with receptor activity within the ghrelin system. In experimental studies GHRP-2 10 mg is primarily analysed in the context of receptor activation GHS-R, regulation of growth hormone secretion and the relationship between peptide signalling and pituitary endocrine response.

In the scientific literature, the peptide GHRP-2 10 mg is described primarily in terms of mechanisms related to the stimulation of the secretion of the GH. Research indicates that GHRP-2 acts both at the pituitary level and through hypothalamic mechanisms, and its activity may complement signalling GHRH. In cellular models, an increase in secretion of GH after exposure to GHRP-2, and simultaneous administration with GRF/GHRH may have had an additive effect, which cemented the importance of this molecule in somatotropic axis research.

Also check out the GHRP-6 peptide reagent 10 mg

Mechanism of GHRP 2 and action at the receptor level 

Research mechanism GHRP-2 10 mg may additionally be described in relation to the receptor GHS-R, a growth hormone secretagogue receptor linked to the ghrelin system. Such a heading reinforces the receptor theme of the description and allows information on peptide signalling to be safely elaborated upon, without reference to therapeutic or functional applications.

At laboratory level GHRP-2 10 mg can be included as a reference compound for analyses of the relationship between short hexapeptide structure, activation of the GHS-R and the pituitary cell response. In this way, the description retains a scientific character while naturally developing phrases related to the mechanism, receptor and somatotropic axis.

An important area of scientific interest also remains the relationship between activity GHRP-2 10 mg and other hormonal axes. Clinical and review publications show that although the GHRP-2 is mainly used as a stimulus to assess secretory reserve GH, This can also stimulate the secretion of ACTH i cortisol, and in some studies an increase was also observed PRL. It is this broader endocrine profile that makes the GHRP-2 remains an interesting research tool not only in the analysis of axes of GH, but also in studies on the interaction between the ghrelin system and the hypothalamic-pituitary-adrenal axis.

GHRP-2 10 mg vs in vitro studies

In in vitro studies GHRP-2 10 mg can be described as a synthetic hexapeptide used to analyse receptor activation GHS-R and the secretory response of pituitary cells. Cellular models allow the relationship between short peptide structure, receptor signalling and changes in secretory GH under controlled experimental conditions.

From a laboratory perspective, the section on in vitro testing further helps to organize information on GHRP-2 10 mg as a research tool for use in analyses of G-protein-coupled receptors, the somatotropic axis and comparisons with other growth hormone secretagogues, such as GHRP-6, ipamorelin or GHRH/GRF.

The use of GHRP-2 10 mg in research

GHRP 2 10 mg finds application in research on the somatotropic axis, receptor GHS-R, ghrelin signalling and mechanisms of regulation of growth hormone secretion. In the literature, this peptide is also described as a compound used in comparative analyses of secretagogues GH, especially when set against GHRH, GHRP 6 and other short peptides with receptor activity.

From a laboratory perspective GHRP 2 10 mg may be included as a research reagent useful in procedures concerning pituitary response, activation of GHS-R, structure-activity relationships and interactions between the ghrelin system and other hormonal axes. This use allows the description to remain scientific and safe, without reference to therapeutic use, dosage or functional effects.

Scientific sources:

1. Publication describing the sequence of GHRP-2 as D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH₂ and its effect on GH secretion in cell models.
2. Work showing that GHRP-2 is a synthetic agonist of the ghrelin system/GH secretagogue receptor.
3. Clinical studies indicating that GHRP-2 can stimulate not only GH, but also ACTH, cortisol and partly PRL.
4. More recent clinical studies on the use of the test GHRP-2 in the assessment of the pituitary axis.

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.